Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Annika Bundscherer"'
Autor:
Bernhard M. Graf, C.L. Lassen, Torsten Schröder, Christoph H. R. Wiese, York Zausig, Annika Bundscherer, G. Bosse
Publikováno v:
Der Anaesthesist. 64:56-64
Background Palliative emergencies describe an acute situation in patients with a life-limiting illness. At present defined curricula for prehospital emergency physician training for palliative emergencies are limited. Simulation-based training (SBT)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6b1f0ee92e9df072ec8a551343316ebe
https://doi.org/10.1007/s00101-014-2388-6
https://doi.org/10.1007/s00101-014-2388-6
Autor:
K Gebhardt, Christoph H. R. Wiese, Annika Bundscherer, Michael Gruber, C Plank, Manuela Malsy, Bernhard M. Graf, Thomas Metterlein
Publikováno v:
Pharmacological research.
The perioperative period is supposed to be a vulnerable period for cancer progression. Results of clinical studies indicate that the use of regional anesthesia can influence and improve oncological outcome of cancer patients. Uncontrolled cell prolif
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::137d92f974f0aebc53e555166027e11d
https://pubmed.ncbi.nlm.nih.gov/25839130
https://pubmed.ncbi.nlm.nih.gov/25839130
Autor:
Annika, Bundscherer, Manuela, Malsy, Renate, Lange, Petra, Hofmann, Thomas, Metterlein, Bernhard M, Graf, Michael, Gruber
Publikováno v:
Anticancer research. 33(8)
Annexin V staining is a common tool in apoptosis analysis. However, in adherently growing cell lines, substantial experimental bias could be introduced by membrane damage during the harvesting process. We investigated the influence of three different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::563468db07b1af364b033bc688e83e49
https://pubmed.ncbi.nlm.nih.gov/23898079
https://pubmed.ncbi.nlm.nih.gov/23898079
Publikováno v:
Anticancer research. 30(10)
Beyond their primary field of application some well-established drugs exhibit antitumour effects in a variety of cancers. The aim of this study was to investigate the effects of the COX2 inhibitor celecoxib and the mTOR antagonist rapamycin on angios
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4345426bb0dd5dc31c56e71b844f2b7c
https://pubmed.ncbi.nlm.nih.gov/21036716
https://pubmed.ncbi.nlm.nih.gov/21036716
Autor:
Annika Bundscherer, Christian Hafner
Publikováno v:
From Molecular to Modular Tumor Therapy ISBN: 9789048195305
In the treatment of chemorefractory and metastatic cancer new concepts such as stroma-targeted and antiangiogenetic strategies emerge as powerful alternatives to conventional regimes. In this context, several well established drugs such as IMiDs, C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8177cee94eb7e3fd85a6e09e982f16e7
https://doi.org/10.1007/978-90-481-9531-2_24
https://doi.org/10.1007/978-90-481-9531-2_24
Publikováno v:
Anti-cancer agents in medicinal chemistry. 9(7)
Tumor cells depend on and are able to modulate the tumor stroma establishing a permissive and supportive environment of their own. Targeting the tumor stroma has evolved as a novel concept that has attracted attention of cancer researchers aiming at
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b55b47555a6ad69d991dfce69d27193d
https://pubmed.ncbi.nlm.nih.gov/19594413
https://pubmed.ncbi.nlm.nih.gov/19594413
Autor:
Christian Hafner, Annika Bundscherer
Publikováno v:
Cancer Microenvironment and Therapeutic Implications ISBN: 9781402095757
Stroma-targeted and antiangiogenetic strategies emerge as a powerful alternative in the treatment of chemorefractory and metastatic cancer. Several well established drugs such as PPARγ agonists, COX 2 inhibitors, mTOR antagonists and thalidomide, wh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8c3f336d61c56f06b6687a691b2bcbd9
https://doi.org/10.1007/978-1-4020-9576-4_12
https://doi.org/10.1007/978-1-4020-9576-4_12
Autor:
Thomas Vogt, Tim Maisch, Bernd Becker, Christian Hafner, Michael Landthaler, Annika Bundscherer
Publikováno v:
Oncology Reports.
Inhibitors of cyclooxygenase 2 (COX 2) and the mammalian target of rapamycin (mTOR) show direct and indirect antitumor effects in a variety of cancers. This study was designed to investigate the effects of the mTOR antagonist rapamycin and the COX 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1412cf275982ca942d95bd6a918ceca
https://doi.org/10.3892/or.19.2.547
https://doi.org/10.3892/or.19.2.547